Immunome
IMNM
IMNM
115 hedge funds and large institutions have $755M invested in Immunome in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 27 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 113 → 115 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
83% less call options, than puts
Call options by funds: $4.72M | Put options by funds: $28.3M
Holders
115
Holding in Top 10
2
Calls
$4.72M
Puts
$28.3M
Top Buyers
| 1 | +$27.5M | |
| 2 | +$27.4M | |
| 3 | +$5.95M | |
| 4 |
Goldman Sachs
New York
|
+$5.62M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$4.74M |
Top Sellers
| 1 | -$12.1M | |
| 2 | -$4.54M | |
| 3 | -$3.6M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$3.43M |
| 5 |
State Street
Boston,
Massachusetts
|
-$2.58M |